Skip to main content
Caplight Logo









Celloram Inc.

Celloram Inc.

Private
Cleveland, OhioHealthcare & Life Scienceshttps://www.celloram.com/

Last Round

Seed

Oct 16, 2020

Total Funding Raised

$9.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Celloram Inc. is a biotechnology company that develops cell-based therapies and small molecule therapeutics for the treatment of cancer, immune disorders, and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoverybiotechsmall-molecule therapeuticscellular immunotherapydendritic cell vaccinepersonalized medicineimmuno-oncologybioinformaticspreclinical researchNLRP3 inhibitorFABP inhibitordrug devbiotech startupdrug licensingcomputational biologyprecision medicinepharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Celloram Inc. Comparables

Compare Celloram Inc. with similar companies based on industry and business-model similarity.

Celloram Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rezq Bio
81%
Tidewave Bio
78%
Cell4Cure AB
77%

Celloram Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 16, 2020

Key People

Founding team and executive leadership

Tej Kumar Pareek

Chief Executive Officer

Executive Team

Celloram Inc. Investors

Notable investors and investment history

Celloram Inc. investors
InvestorRounds
Winvest Venture CapitalSeed
U.S. Department of WarGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    Hiring one role, representing 33% of current headcount.

  • May 17, 2026

    Monthly visitors grew 694% MoM to 1.3K.

Celloram Inc. Filings

Explore SEC and related filing metadata, where available.

Celloram Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Celloram Inc.'s valuation, stock price, and market status.

Is Celloram Inc. a public or private company?

Celloram Inc. is a private company.

What is the current stock price of Celloram Inc.?

Celloram Inc. is a private company with no public stock price. Caplight tracks Celloram Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Celloram Inc. worth (valuation)?

Valuation information for Celloram Inc. is not publicly available.

Can I buy Celloram Inc. stock?

Celloram Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Celloram Inc.'s last funding round?

Celloram Inc.'s most recent funding round was Seed on October 16, 2020.

Who are the main investors in Celloram Inc.?

Key investors in Celloram Inc. include Winvest Venture Capital, U.S. Department of War.

Will Celloram Inc. IPO soon?

No public IPO plans have been announced for Celloram Inc..

How can I track Celloram Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Celloram Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCleveland, Ohio
Employee Range3
Year Founded2018
Last FundingOct 16, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?